perflutren has been researched along with Coronary Heart Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almería, C; Aubele, A; Luis Rodrigo, J; Luis Zamorano, J; Pérez de Isla, L; Serra, V | 1 |
| Bajwa, F; Chaudhry, FA; Dukkipati, SS; Kahan, J; Makani, H; Pierce, M; Supariwala, A; Teixeira, J | 1 |
| Chen, LX; Fei, HW; Huang, RQ; Miller, AP; Nanda, NC; Wang, J; Wang, LY; Wang, XF; Xie, MX; Yang, Y; Zhuang, L | 1 |
| Fathi, R; Haluska, BA; Jenkins, C; Marwick, TH; Moir, S | 1 |
| Hankins, J; Mahrous, H; McGrain, AC; O'leary, EL; Porter, TR; Tsutsui, JM; Xie, F | 1 |
| Hankins, J; Mahrous, HA; Porter, TR; Xie, F | 1 |
| Baisch, C; Kuersten, B; Li, P; Liu, Z; Locricchio, E; Murthy, TH; Rafter, P; Vannan, M | 1 |
1 review(s) available for perflutren and Coronary Heart Disease
| Article | Year |
|---|---|
Myocardial contrast echocardiography in the assessment of patients with chronic coronary artery disease.
Topics: Albumins; Blood Volume; Chronic Disease; Contrast Media; Coronary Circulation; Coronary Disease; Echocardiography; Fluorocarbons; Humans; Microcirculation; Phospholipids; Polysaccharides; Prognosis; Sulfur Hexafluoride | 2003 |
6 other study(ies) available for perflutren and Coronary Heart Disease
| Article | Year |
|---|---|
Feasibility and prognostic value of stress echocardiography in obese, morbidly obese, and super obese patients referred for bariatric surgery.
Topics: Adult; Albumins; Analysis of Variance; Bariatric Surgery; Body Mass Index; Cohort Studies; Contrast Media; Coronary Disease; Echocardiography, Stress; Feasibility Studies; Female; Fluorocarbons; Follow-Up Studies; Humans; Image Enhancement; Male; Middle Aged; Obesity; Obesity, Morbid; Preoperative Care; Prognosis; Retrospective Studies | 2014 |
Real-time three-dimensional myocardial contrast echocardiography in assessment of myocardial perfusion defects.
Topics: Animals; Coronary Disease; Dogs; Echocardiography; Echocardiography, Three-Dimensional; Feasibility Studies; Fluorocarbons | 2004 |
Incremental benefit of myocardial contrast to combined dipyridamole-exercise stress echocardiography for the assessment of coronary artery disease.
Topics: Aged; Comorbidity; Contrast Media; Coronary Angiography; Coronary Circulation; Coronary Disease; Dipyridamole; Echocardiography, Stress; Exercise Test; Female; Fluorocarbons; Humans; Hyperemia; Liposomes; Male; Middle Aged; Risk Factors; Sensitivity and Specificity; Single-Blind Method | 2004 |
Comparison of low-mechanical index pulse sequence schemes for detecting myocardial perfusion abnormalities during vasodilator stress echocardiography.
Topics: Coronary Angiography; Coronary Disease; Dipyridamole; Echocardiography, Stress; Female; Fluorocarbons; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2005 |
Detection of coronary artery disease with a continuous infusion of definity ultrasound contrast during adenosine stress real time perfusion echocardiography.
Topics: Adenosine; Coronary Angiography; Coronary Circulation; Coronary Disease; Echocardiography; Exercise Test; Female; Fluorocarbons; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Microspheres; Middle Aged; Observer Variation; Reproducibility of Results; Retrospective Studies; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2007 |
Ultraharmonic myocardial contrast imaging: in vivo experimental and clinical data from a novel technique.
Topics: Adult; Animals; Contrast Media; Coronary Circulation; Coronary Disease; Dipyridamole; Dogs; Echocardiography; Female; Fluorocarbons; Humans; Image Enhancement; Male; Microspheres; Phosphodiesterase Inhibitors; Ultrasonics | 2001 |